Subscribe to our newsletter

Pedro Folegatti

PhD Candidate in Clinical Medicine, University of Oxford

Infectious diseases physician with experience in clinical trials, vaccine research, public health, tropical medicine, general infectious diseases and internal medicine.

I am currently working on influenza and emerging pathogens vaccine clinical development.

From This Author

Oxford Scientists: These Are Final Steps We’re Taking to Get Our Coronavirus Vaccine Approved

Of the hundreds of potential Covid-19 vaccines in development, six are in the final stages of testing, known as phase three clinical trials. One of these—ChAdOx1 nCoV-19—is the vaccine we’re developing at the University...

Singularity University, Singularity Hub, Singularity Summit, SU Labs, Singularity Labs, Exponential Medicine, Exponential Finance and all associated logos and design elements are trademarks and/or service marks of Singularity Education Group.

© 2021 Singularity Education Group. All Rights Reserved.

Singularity University is not a degree granting institution.